These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 27743567)

  • 41. Contrast-enhanced ultrasound (CEUS) for the evaluation of focal liver lesions - a prospective multicenter study of its usefulness in clinical practice.
    Sporea I; Badea R; Popescu A; Spârchez Z; Sirli RL; Dănilă M; Săndulescu L; Bota S; Calescu DP; Nedelcu D; Brisc C; Ciobâca L; Gheorghe L; Socaciu M; Martie A; Ioaniţescu S; Tamas A; Streba CT; Iordache M; Simionov I; Jinga M; Anghel A; Cijevschi Prelipcean C; Mihai C; Stanciu SM; Stoicescu D; Dumitru E; Pietrareanu C; Bartos D; Manzat Saplacan R; Pârvulescu I; Vădan R; Smira G; Tuţă L; Săftoiu A
    Ultraschall Med; 2014 Jun; 35(3):259-66. PubMed ID: 24563420
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Half-dose gadobenate dimeglumine versus standard-dose gadodiamide in dynamic magnetic resonance imaging of non-cirrhotic livers: a retrospective intra-individual crossover comparison.
    Homayoon B; Diwakar H; Strovski E; Bakshi D; Harris AC; Thoeni RF; Chang SD
    Abdom Imaging; 2014 Oct; 39(5):955-62. PubMed ID: 24676875
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Application of liver-specific contrast agents for evaluation of focal liver lesions - Expert recommendations from the Gastrointestinal and Abdominal Imaging Workgroup of the German Roentgen Society.
    Ringe KI; Fischbach F; Grenacher L; Juchems MS; Kukuk G; Lauenstein T; Wessling J; Schreyer AG
    Rofo; 2024 Jul; 196(7):690-698. PubMed ID: 38113896
    [No Abstract]   [Full Text] [Related]  

  • 44. Contrast agents for MR imaging of the liver.
    Balci NC; Semelka RC
    Radiol Clin North Am; 2005 Sep; 43(5):887-98, viii. PubMed ID: 16098345
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Technical and practical considerations for permeability modeling of dynamic contrast enhanced MRI.
    Roberts T
    Acad Radiol; 2005 May; 12 Suppl 1():S34-7. PubMed ID: 16106544
    [No Abstract]   [Full Text] [Related]  

  • 46. Gadolinium-enhanced liver magnetic resonance imaging using a 2-point Dixon fat-water separation technique: impact upon image quality and lesion detection.
    Rosenkrantz AB; Mannelli L; Kim S; Babb JS
    J Comput Assist Tomogr; 2011; 35(1):96-101. PubMed ID: 21160433
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Dynamic MR imaging of the biliary system using hepatocyte-specific contrast agents.
    Gupta RT; Brady CM; Lotz J; Boll DT; Merkle EM
    AJR Am J Roentgenol; 2010 Aug; 195(2):405-13. PubMed ID: 20651197
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Dynamic contrast-enhanced MR imaging of the liver: current status and future directions.
    Do RK; Rusinek H; Taouli B
    Magn Reson Imaging Clin N Am; 2009 May; 17(2):339-49. PubMed ID: 19406362
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Magnetic resonance imaging of primary pediatric liver tumors.
    Pugmire BS; Towbin AJ
    Pediatr Radiol; 2016 May; 46(6):764-77. PubMed ID: 27229495
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Single-breath-hold thin-slice gadoxetic acid-enhanced hepatobiliary MR imaging using a newly developed three-dimensional fast spoiled gradient-echo sequence.
    Hori M; Kim T; Onishi H; Takei N; Wakayama T; Sakane M; Dia AA; Tsuboyama T; Nakamoto A; Tatsumi M; Tomiyama N
    Magn Reson Imaging; 2016 May; 34(4):545-51. PubMed ID: 26747408
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Improved parenchymal liver enhancement with extended delay on Gd-EOB-DTPA-enhanced MRI in patients with parenchymal liver disease: associated clinical and imaging factors.
    Esterson YB; Flusberg M; Oh S; Mazzariol F; Rozenblit AM; Chernyak V
    Clin Radiol; 2015 Jul; 70(7):723-9. PubMed ID: 25921617
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Contrast agents as a biological marker in magnetic resonance imaging of the liver: conventional and new approaches.
    Sommer WH; Sourbron S; Huppertz A; Ingrisch M; Reiser MF; Zech CJ
    Abdom Imaging; 2012 Apr; 37(2):164-79. PubMed ID: 21516381
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Part 1: MRI features of focal nodular hyperplasia with an emphasis on hepatobiliary contrast agents.
    Sutherland T; Seale M; Yap K
    J Med Imaging Radiat Oncol; 2014 Feb; 58(1):50-5. PubMed ID: 24171783
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Biliary tract depiction in living potential liver donors: comparison of conventional MR, mangafodipir trisodium-enhanced excretory MR, and multi-detector row CT cholangiography--initial experience.
    Yeh BM; Breiman RS; Taouli B; Qayyum A; Roberts JP; Coakley FV
    Radiology; 2004 Mar; 230(3):645-51. PubMed ID: 14990830
    [TBL] [Abstract][Full Text] [Related]  

  • 55. MR imaging of benign focal liver lesions.
    Ba-Ssalamah A; Baroud S; Bastati N; Qayyum A
    Magn Reson Imaging Clin N Am; 2010 Aug; 18(3):403-19, ix. PubMed ID: 21094447
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Radiologic diagnosis of liver diseases--method development taking place on a wide front].
    Blomqvist L; Bremmer S; Jersenius U; Siösteen AK; von Sivers K; Hultcrantz R
    Lakartidningen; 2003 Nov; 100(46):3750-5. PubMed ID: 14655331
    [TBL] [Abstract][Full Text] [Related]  

  • 57. New technologies in clinical ultrasound.
    Kamaya A; Machtaler S; Safari Sanjani S; Nikoozadeh A; Graham Sommer F; Pierre Khuri-Yakub BT; Willmann JK; Desser TS
    Semin Roentgenol; 2013 Jul; 48(3):214-23. PubMed ID: 23796372
    [No Abstract]   [Full Text] [Related]  

  • 58. Contrast enhanced ultrasound (CEUS) characterization of grey-scale sonographic indeterminate focal liver lesions in pediatric practice.
    Jacob J; Deganello A; Sellars ME; Hadzic N; Sidhu PS
    Ultraschall Med; 2013 Dec; 34(6):529-40. PubMed ID: 24132647
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Focal nodular hyperplasia.
    Vilgrain V
    Eur J Radiol; 2006 May; 58(2):236-45. PubMed ID: 16414229
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Hepatic magnetic resonance imaging: new techniques and contrast agents.
    Mahfouz AE; Hamm B; Taupitz M
    Endoscopy; 1997 Aug; 29(6):504-14. PubMed ID: 9342568
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.